Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Free Report) – Analysts at HC Wainwright issued their Q1 2024 EPS estimates for Cyclo Therapeutics in a research note issued to investors on Wednesday, May 1st. HC Wainwright analyst S. Ramakanth expects that the company will post earnings of ($0.20) per share for the quarter. HC Wainwright has a […]